Announcing a new publication for Acta Materia Medica journal. Treatment of cancer can be challenging, because of the disease’s intricate and varied nature.
What we owe ALS patients — and why one company fell short
What do you say to a patient when the FDA rejects “their” experimental drug — one that they believe can alleviate at least some of